{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T10:39:37Z","timestamp":1792492777634,"version":"4.5.0"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.msard.2026.107990","type":"journal-article","created":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:21:13Z","timestamp":1792077673000},"page":"107990","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Comment on \u201cLacosamide effects on pain management in patients with multiple sclerosis: A randomized, double-blind, placebo-controlled clinical trial\u201d"],"prefix":"10.1016","volume":"116","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-5994-2970","authenticated-orcid":false,"given":"Antonio","family":"Alc\u00e1ntara Montero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Almudena","family":"Holguera Palacios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.msard.2026.107990_bib0008","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/head.14399","article-title":"Off-label use of lacosamide, an alternative for the treatment of neuropathic pain","volume":"62","author":"Alc\u00e1ntara Montero","year":"2022","journal-title":"Headache"},{"issue":"1","key":"10.1016\/j.msard.2026.107990_bib0006","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/ejp.2165","article-title":"The effect of lacosamide in peripheral neuropathic pain: a randomized, double-blind, placebo-controlled, phenotype-stratified trial","volume":"28","author":"Carmland","year":"2024","journal-title":"Eur. J. Pain."},{"key":"10.1016\/j.msard.2026.107990_bib0009","doi-asserted-by":"crossref","first-page":"e2229","DOI":"10.1136\/spcare-2024-005063","article-title":"Parenteral lacosamide for complex neuropathic pain","volume":"14","author":"Crispin","year":"2024","journal-title":"BMJ Support. Palliat. Care"},{"issue":"5","key":"10.1016\/j.msard.2026.107990_bib0003","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s40263-022-00914-4","article-title":"Central neuropathic pain syndromes: current and emerging pharmacological strategies","volume":"36","author":"Gurba","year":"2022","journal-title":"CNS. Drugs"},{"issue":"5","key":"10.1016\/j.msard.2026.107990_bib0005","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3390\/neurolint17050077","article-title":"Medications for managing Central neuropathic pain as a result of underlying conditions-A systematic review","volume":"17","author":"Houlind","year":"2025","journal-title":"Neurol. Int."},{"issue":"8","key":"10.1016\/j.msard.2026.107990_bib0007","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1080\/14737175.2026.2688513","article-title":"Clinical efficacy of lacosamide in neuropathic pain: a systematic review of randomized controlled trials","volume":"26","author":"Kaur","year":"2026","journal-title":"Expert. Rev. NeurOther"},{"key":"10.1016\/j.msard.2026.107990_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2026.107952","article-title":"Lacosamide effects on pain management in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled clinical trial","volume":"115","author":"Nouri","year":"2026","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"1","key":"10.1016\/j.msard.2026.107990_bib0002","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41572-023-00484-9","article-title":"Central neuropathic pain","volume":"9","author":"Rosner","year":"2023","journal-title":"Nat. Rev. Dis. Primers."},{"issue":"12","key":"10.1016\/j.msard.2026.107990_bib0010","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.3390\/brainsci12121727","article-title":"Review of the treatments for Central neuropathic pain","volume":"12","author":"Sheldon","year":"2022","journal-title":"Brain Sci."},{"issue":"5","key":"10.1016\/j.msard.2026.107990_bib0004","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1007\/s12325-020-01334-w","article-title":"Central neuropathic mechanisms in pain signaling pathways: current evidence and recommendations","volume":"37","author":"Viswanath","year":"2020","journal-title":"Adv. Ther."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826010254?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826010254?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T09:52:51Z","timestamp":1792489971000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034826010254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":10,"alternative-id":["S2211034826010254"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2026.107990","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comment on \u201cLacosamide effects on pain management in patients with multiple sclerosis: A randomized, double-blind, placebo-controlled clinical trial\u201d","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2026.107990","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107990"}}